Endovascular Treatment and RIPC in Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT04581759
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT04581759
-
- Other papers using this trial's data
- Remote Ischemic Postconditioning in Endovascular Thrombectomy for Stroke: The EnTRIPS Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04581759. Randomized; quadruple masking; primary purpose treatment. Start 2021-04-12 (actual); primary completion 2023-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endovascular Treatment and RIPC in Acute Ischemic Stroke
- Acronym
- EnTRIPS
- Condition
- Acute Ischemic Stroke
- Condition
- Endovascular Treatment
- Intervention (Device)
- RIPC device (IPC-906X)
- Intervention (Drug)
- foundational treatment
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Collaborator
- Second Affiliated Hospital of Xi'an Jiaotong University
- Collaborator
- Shaanxi Provincial People's Hospital
- Collaborator
- Xijing Hospital
- Collaborator
- Tang-Du Hospital
- Collaborator
- Xi'an No.3 Hospital
- Collaborator
- Xi'an Gaoxin Hospital
Record details
- Record id
cardio:ct-nct04581759- Content hash
00fdd94d265b7374b94e919b3eccce658696f1ffa278f2877c472a956bbcd5ad